Alternative methods in toxicology: CFU assays application, limitation and future prospective

Abstract Blood is a fluid connective tissue which plays a vital role for normal body function. It consist different type of blood cells which is continuously reproduce inside the bone marrow from hematopoietic system. Xenobiotics could be specifically toxic to the hematopoietic system and they can cause hematological disorders by disturbing the normal functions. In vitro hematopoietic colony-forming cell assays play a crucial role to evaluate potential toxic effects of new xenobiotics and also helpful in bridging the gap between preclinical toxicology studies in animal models and clinical investigations. Use of these assays in conjunction with, high-throughput screening reduces the cost and time associated with these assays. This article provides a critical view over in vitro hematopoietic colony-forming cell assays in assessment of hematotoxicity.

[1]  Melissa M. Sprachman,et al.  Evaluation of potential ionizing irradiation protectors and mitigators using clonogenic survival of human umbilical cord blood hematopoietic progenitor cells. , 2013, Experimental hematology.

[2]  J. Denburg,et al.  Toll‐like receptor‐mediated eosinophil–basophil differentiation: autocrine signalling by granulocyte–macrophage colony‐stimulating factor in cord blood haematopoietic progenitors , 2013, Immunology.

[3]  S. Hackenberg,et al.  Effects of salinomycin on human bone marrow-derived mesenchymal stem cells in vitro. , 2013, Toxicology letters.

[4]  P. Woll,et al.  Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34+ progenitor cells , 2013, British journal of haematology.

[5]  S. Law,et al.  Pesticide induced marrow toxicity and effects on marrow cell population and on hematopoietic stroma. , 2013, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[6]  F. Konietschke,et al.  Iron overload impairs proliferation of erythroid progenitors cells (BFU-E) from patients with myelodysplastic syndromes. , 2013, Leukemia research.

[7]  Hubert T. Kim,et al.  Cytotoxicity of local anesthetics on human mesenchymal stem cells. , 2013, The Journal of bone and joint surgery. American volume.

[8]  F. Baron,et al.  Imatinib and Nilotinib Inhibit Hematopoietic Progenitor Cell Growth, but Do Not Prevent Adhesion, Migration and Engraftment of Human Cord Blood CD34+ Cells , 2012, PloS one.

[9]  M. H. Abnosi,et al.  Low Dose and Long Term Toxicity of Sodium Arsenite Caused Caspase Dependent Apoptosis Based on Morphology and Biochemical Character , 2012, Cell journal.

[10]  J. Sims,et al.  A whole blood in vitro cytokine release assay with aqueous monoclonal antibody presentation for the prediction of therapeutic protein induced cytokine release syndrome in humans. , 2012, Cytokine.

[11]  L. Tang,et al.  Characterization of bone marrow derived mesenchymal stem cells in suspension , 2012, Stem Cell Research & Therapy.

[12]  Jinsheng Xu,et al.  Development of a novel, physiologically relevant cytotoxicity model: application to the study of chemotherapeutic damage to mesenchymal stromal cells. , 2012, Toxicology and applied pharmacology.

[13]  Shaorong Gao,et al.  Pluripotency of induced pluripotent stem cells , 2012, Journal of Animal Science and Biotechnology.

[14]  S. Law,et al.  Alteration in Marrow Stromal Microenvironment and Apoptosis Mechanisms Involved in Aplastic Anemia: An Animal Model to Study the Possible Disease Pathology , 2010, Stem cells international.

[15]  X. Pei,et al.  Production of erythriod cells from human embryonic stem cells by fetal liver cell extract treatment , 2010, BMC Developmental Biology.

[16]  M. Höglund,et al.  The FMCA-GM assays, high throughput non-clonogenic alternatives to CFU-GM in preclinical hematotoxicity testing. , 2010, Toxicology letters.

[17]  D. Parent-Massin,et al.  Prevalidation of the Rat CFU-GM Assay for In Vitro Toxicology Applications , 2010, Alternatives to laboratory animals : ATLA.

[18]  G. Ehninger,et al.  Hematopoietic stem cells in co-culture with mesenchymal stromal cells - modeling the niche compartments in vitro , 2010, Haematologica.

[19]  A. Castoldi,et al.  Comparative in vitro and ex-vivo myelotoxicity of aflatoxins B1 and M1 on haematopoietic progenitors (BFU-E, CFU-E, and CFU-GM): species-related susceptibility. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[20]  D. Parent-Massin,et al.  Stem cells in myelotoxicity. , 2010, Toxicology.

[21]  L. Gribaldo,et al.  Refinement and Optimisation of the Rat CFU-GM Assay to Incorporate the Use of Cryopreserved Bone-marrow Cells for In Vitro Toxicology Applications , 2009, Alternatives to laboratory animals : ATLA.

[22]  D Parent-Massin,et al.  Application of human CFU-Mk assay to predict potential thrombocytotoxicity of drugs. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.

[23]  L. Gribaldo,et al.  In vitro toxicity of naphthalene, 1-naphthol, 2-naphthol and 1,4-naphthoquinone on human CFU-GM from female and male cord blood donors. , 2008, Toxicology in vitro : an international journal published in association with BIBRA.

[24]  G. Bowe,et al.  Toxicity of inorganic arsenic and its metabolites on haematopoietic progenitors "in vitro": comparison between species and sexes. , 2008, Toxicology.

[25]  R. Pieters,et al.  TBTC induces adipocyte differentiation in human bone marrow long term culture. , 2008, Toxicology.

[26]  J. Loring,et al.  Hematopoietic differentiation of embryonic stem cells. , 2008, Methods.

[27]  S. McKeag,et al.  The haemotoxicity of azathioprine in repeat dose studies in the female CD‐1 mouse , 2008, International journal of experimental pathology.

[28]  J. Damen,et al.  Toxicity testing using hematopoietic stem cell assays. , 2007, Regenerative medicine.

[29]  A. Pessina,et al.  CFU‐GM Assay for Evaluation of Drug Myelotoxic Activity , 2007, Current protocols in toxicology.

[30]  T. Nakahata,et al.  Novel Method for Efficient Production of Multipotential Hematopoietic Progenitors from Human Embryonic Stem Cells , 2007, International journal of hematology.

[31]  M. Vita,et al.  Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro , 2007, Cancer Chemotherapy and Pharmacology.

[32]  J. Thomson,et al.  Differential Requirements for Hematopoietic Commitment Between Human and Rhesus Embryonic Stem Cells , 2007, Stem cells.

[33]  T Hartung,et al.  In vitro tests to evaluate immunotoxicity: a preliminary study. , 2007, Toxicology.

[34]  Davide Sciuscio,et al.  A new experimental protocol as an alternative to the colony-forming unit-granulocyte/macrophage (CFU-GM) clonogenic assay to assess the haematotoxic potential of new drugs. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[35]  Davide Sciuscio,et al.  Toward refinement of the colony-forming unit-granulocyte/macrophage clonogenic assay: inclusion of a metabolic system. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[36]  F. Baron,et al.  Despite Inhibition of Hematopoietic Progenitor Cell Growth In Vitro, the Tyrosine Kinase Inhibitor Imatinib Does Not Impair Engraftment of Human CD133+ Cells into NOD/SCIDβ2mNull Mice , 2006, Stem cells.

[37]  I. Rich,et al.  Validation and development of a predictive paradigm for hemotoxicology using a multifunctional bioluminescence colony-forming proliferation assay. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[38]  C. Diodovich,et al.  Gene and protein expressions in human cord blood cells after exposure to acrylonitrile , 2005, Journal of biochemical and molecular toxicology.

[39]  C. Diodovich,et al.  Sensitivity of human cord blood cells to tetrachloroethylene: cellular and molecular endpoints , 2005, Archives of Toxicology.

[40]  L. Gribaldo,et al.  Hematotoxicity testing by cell clonogenic assay in drug development and preclinical trials. , 2005, Current pharmaceutical design.

[41]  Thomas Heinemann,et al.  Klonieren beim Menschen : Analyse des Methodenspektrums und internationaler Vergleich der ethischen Bewertungskriterien , 2005 .

[42]  D. Scadden,et al.  Regulation of hematopoietic stem cell growth , 2004, Leukemia.

[43]  Jonathan L. Linehan,et al.  Cytokine requirements differ for stroma and embryoid body-mediated hematopoiesis from human embryonic stem cells. , 2004, Experimental hematology.

[44]  Gerard Bowe,et al.  Response of human cord blood cells to styrene exposure: evaluation of its effects on apoptosis and gene expression by genomic technology. , 2004, Toxicology.

[45]  C. Diodovich,et al.  Inhibition of CFU-E/BFU-E and CFU-GM colony growth by cyclophosphamide, 5-fluorouracil and taxol: development of a high-throughput in vitro method. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.

[46]  L. Gribaldo,et al.  A Methylcellulose Microculture Assay for the In Vitro Assessment of Drug Toxicity on Granulocyte/macrophage Progenitors (CFU-GM) , 2004, Alternatives to laboratory animals : ATLA.

[47]  S. Holm.  Stem Cell Transplantation and Ethics: A European Overview , 2004, Fetal Diagnosis and Therapy.

[48]  D Parent-Massin,et al.  Application of the CFU-GM assay to predict acute drug-induced neutropenia: an international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[49]  D. Volpe,et al.  Myeloid clonogenic assays for comparison of the in vitro toxicity of alkylating agents. , 2003, Toxicology in vitro : an international journal published in association with BIBRA.

[50]  L. Gribaldo,et al.  Refinement of the colony-forming unit-megakaryocyte (CFU-MK) assay for its application to pharmaco-toxicological testing. , 2003, Toxicology in vitro : an international journal published in association with BIBRA.

[51]  Silvia Casati,et al.  In Vitro Tests for Haematotoxicity: Prediction of Drug-induced Myelosuppression by the CFU-GM Assay , 2002, Alternatives to laboratory animals : ATLA.

[52]  Thomas M. Schmitt,et al.  Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. , 2002, Immunity.

[53]  D. Parent-Massin,et al.  In vitro myelotoxicity of propanil and 3,4-dichloroaniline on murine and human CFU-E/BFU-E progenitors. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[54]  A. Verma,et al.  Activation of the p38 Mitogen-activated Protein Kinase Mediates the Suppressive Effects of Type I Interferons and Transforming Growth Factor-β on Normal Hematopoiesis* , 2002, The Journal of Biological Chemistry.

[55]  D. Parent-Massin,et al.  Prevalidation of a model for predicting acute neutropenia by colony forming unit granulocyte/macrophage (CFU-GM) assay. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[56]  D. Parent-Massin,et al.  Improvement of megakaryocytic progenitor culture for toxicological investigations. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[57]  D. Greenwalt,et al.  High Throughput Cell-Based Assay of Hematopoietic Progenitor Differentiation , 2001, Journal of biomolecular screening.

[58]  C. Eaves,et al.  Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0). , 2000, Blood.

[59]  L. Gribaldo,et al.  Inhibition of CFU-E/BFU-E by 3'-azido-3'-deoxythymidine, chlorpropamide, and protoporphirin IX zinc (II): a comparison between direct exposure of progenitor cells and long-term exposure of bone marrow cultures. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[60]  D. Horowitz,et al.  Colorimetric determination of inhibition of hematopoietic progenitor cells in soft agar. , 2000, Journal of immunological methods.

[61]  D. Bryder,et al.  Interleukin-3 supports expansion of long-term multilineage repopulating activity after multiple stem cell divisions in vitro , 2000 .

[62]  H. Denker.  Embryonic Stem Cells: An Exciting Field for Basic Research and Tissue Engineering, but also an Ethical Dilemma? , 1999, Cells Tissues Organs.

[63]  L. Gribaldo,et al.  Role of SR-4987 stromal cells in the modulation of doxorubicin toxicity to in vitro granulocyte-macrophage progenitors (CFU-GM). , 1999, Life sciences.

[64]  L. Gribaldo,et al.  In vitro myelotoxicity of environmental contaminants. , 1998, Environmental toxicology and pharmacology.

[65]  F. Cavalli,et al.  Hematotoxicity on human bone marrow- and umbilical cord blood-derived progenitor cells and in vitro therapeutic index of methoxymorpholinyldoxorubicin and its metabolites , 1998, Cancer Chemotherapy and Pharmacology.

[66]  M. Ghielmini,et al.  Predicting hematological toxicity (myelosuppression) of cytotoxic drug therapy from in vitro tests. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[67]  R. Parchment.  Alternative testing systems for evaluating noncarcinogenic, hematologic toxicity. , 1998, Environmental health perspectives.

[68]  G Cossu,et al.  Muscle regeneration by bone marrow-derived myogenic progenitors. , 1998, Science.

[69]  R. Class,et al.  Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[70]  Cindy L. Miller,et al.  Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting ability. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[71]  D. Parent-Massin,et al.  In vitro toxicity of trichothecenes on human erythroblastic progenitors , 1997, Human & experimental toxicology.

[72]  D. Prockop.  Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.

[73]  D. Parent-Massin,et al.  Effects of a diphenyl-ether herbicide, oxyfluorfen, on human BFU-E/CFU-E development and haemoglobin synthesis , 1997, Human & experimental toxicology.

[74]  J. Bueren,et al.  Analysis of hematopoiesis in mice irradiated with 500 mGy of X rays at different stages of development. , 1995, Radiation research.

[75]  Michael Balls,et al.  The Role of Prevalidation in the Development, Validation and Acceptance of Alternative Methods , 1995 .

[76]  Robert D. Combes,et al.  Practical Aspects of the Validation of Toxicity Test Procedures , 1995 .

[77]  R. Parchment,et al.  In vivo-in vitro correlation of myelotoxicity of 9-methoxypyrazoloacridine (NSC-366140, PD115934) to myeloid and erythroid hematopoietic progenitors from human, murine, and canine marrow. , 1994, Journal of the National Cancer Institute.

[78]  D. Parent-Massin,et al.  In vitro study of pesticide hematotoxicity in human and rat progenitors. , 1993, Journal of pharmacological and toxicological methods.

[79]  M. Gordon.  Human haemopoietic stem cell assays. , 1993, Blood reviews.

[80]  B. Naughton,et al.  Differential Effects of Drugs upon Hematopoiesis Can Be Assessed in Long-Term Bone Marrow Cultures Established on Nylon Screens , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[81]  R. Hoffman,et al.  Role of c-kit ligand in the expansion of human hematopoietic progenitor cells. , 1992, Blood.

[82]  Lemischka Ir.  Clonal, in vivo behavior of the totipotent hematopoietic stem cell. , 1991 .

[83]  I. Weissman,et al.  Mouse hematopoietic stem cells. , 1991, Blood.

[84]  A. Caplan.  Mesenchymal Stem Cells , 1991, Cartilage.

[85]  B. Naughton,et al.  Hematopoiesis on Nylon Mesh Templates Comparative Long‐Term Bone Marrow Culture and the Influence of Stromal Support Cells a , 1989, Annals of the New York Academy of Sciences.

[86]  A. Friedenstein,et al.  Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers , 1987, Cell and tissue kinetics.

[87]  A. Piersma,et al.  Characterization of fibroblastic stromal cells from murine bone marrow. , 1985, Experimental hematology.

[88]  O. Witte,et al.  Long-term culture of B lymphocytes and their precursors from murine bone marrow. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[89]  G. Verdonk,et al.  In vitro aging of human bone marrow derived stromal cells , 1981, Mechanisms of Ageing and Development.

[90]  H. Broxmeyer,et al.  Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. , 1980, Blood.

[91]  T. Dexter,et al.  Long‐Term Production of Erythroid Precursor Cells (BFU) in Bone Marrow Cultures , 1977 .

[92]  N. Kulagina,et al.  Fibroblast precursors in normal and irradiated mouse hematopoietic organs. , 1976, Experimental hematology.

[93]  E. McCulloch,et al.  Erythropietic colonies in cultures of human marrow. , 1974, Blood.

[94]  J. Stephenson,et al.  Induction of colonies of hemoglobin-synthesizing cells by erythropoietin in vitro. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[95]  A. Friedenstein,et al.  THE DEVELOPMENT OF FIBROBLAST COLONIES IN MONOLAYER CULTURES OF GUINEA‐PIG BONE MARROW AND SPLEEN CELLS , 1970, Cell and tissue kinetics.

[96]  Cindy L. Miller,et al.  Colony forming cell assays for human hematopoietic progenitor cells. , 2013, Methods in molecular biology.

[97]  J. Damen.  The CFU Assay in Preclinical Toxicity Testing: An In Vitro Tool for Predicting In Vivo Cytopenia , 2012 .

[98]  M. Alpers,et al.  Alternative methods in toxicology: pre-validated and validated methods , 2011, Interdisciplinary toxicology.

[99]  M. Vemuri,et al.  Mesenchymal Stem Cell Assays and Applications , 2011, Methods in Molecular Biology.

[100]  H. Denker.  Induced pluripotent stem cells: how to deal with the developmental potential. , 2009, Reproductive biomedicine online.

[101]  G. de Haan,et al.  In vitro assays for cobblestone area-forming cells, LTC-IC, and CFU-C. , 2008, Methods in molecular biology.

[102]  R. Pochampally.  Colony forming unit assays for MSCs. , 2008, Methods in molecular biology.

[103]  J. Damen,et al.  Hematopoietic colony-forming cell assays. , 2007, Methods in molecular biology.

[104]  M. Bhatia.  Hematopoietic development from human embryonic stem cells. , 2007, Hematology. American Society of Hematology. Education Program.

[105]  B. Steinbock.  The science, policy, and ethics of stem cell research , 2007 .

[106]  S. Holm.  Embryonic stem cell research and the moral status of human embryos. , 2005, Reproductive biomedicine online.

[107]  R. Van Den Heuvel,et al.  Use of in vitro assays to assess hematotoxic effects of environmental compounds , 2004, Cell Biology and Toxicology.

[108]  L. Gribaldo,et al.  In vitro bone marrow granulocyte-macrophage progenitor cultures in the assessment of hematotoxic potential of the new drugs , 2004, Cell Biology and Toxicology.

[109]  D. Parent-Massin.  Relevance of clonogenic assays in hematotoxicology , 2004, Cell Biology and Toxicology.

[110]  R. Parchment,et al.  Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro , 1997, Cancer Chemotherapy and Pharmacology.

[111]  B. R. D. Parent-Massin.  IMPROVEMENT OF ERYTHROBLASTIC PROGENITOR CULTURE FOR TOXICOLOGICAL INVESTIGATIONS , 1997 .